Teza Capital Management LLC Spectrum Pharmaceuticals Inc Transaction History

Teza Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $6,521 - $16,459	-10,352 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$2.15 - $3.82 $3,276 - $5,821	-1,524 Reduced 12.83%	10,352 $23,000
Q1 2021 May 13, 2021	SELL	$2.9 - $4.09 $3,912 - $5,517	-1,349 Reduced 10.2%	11,876 $39,000
Q4 2020 Feb 12, 2021	SELL	$3.38 - $5.14 $20,029 - $30,459	-5,926 Reduced 30.94%	13,225 $45,000
Q3 2020 Nov 12, 2020	SELL	$2.99 - $4.9 $41,489 - $67,992	-13,876 Reduced 42.01%	19,151 $78,000
Q2 2020 Aug 10, 2020	SELL	$2.11 - $3.38 $331 - $530	-157 Reduced 0.47%	33,027 $112,000
Q1 2020 May 11, 2020	SELL	$1.83 - $3.45 $37,952 - $71,549	-20,739 Reduced 38.46%	33,184 $77,000
Q4 2019 Feb 12, 2020	BUY	$3.5 - $10.35 $149,338 - $441,613	42,668 Added 379.1%	53,923 $196,000
Q3 2019 Nov 12, 2019	BUY	$7.03 - $9.7 $79,122 - $109,173	11,255 New	11,255 $93,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.